The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Pathophysiology and Mechanisms of Severe Retinopathy of Prematurity
Open accessAbstract
Retinopathy of prematurity (ROP) affects only premature infants, but as premature births increase in many areas of the world, ROP has become a leading cause of childhood blindness. Blindness can occur from aberrant developmental angiogenesis that leads to fibrovascular retinal detachment. In order to treat severe ROP, it is important to study normal developmental angiogenesis and the stresses that activate pathologic signaling events and aberrant angiogenesis in ROP. Vascular endothelial growth factor (VEGF) signaling is important in both physiologic and pathologic developmental angiogenesis. Based on studies in animal models of oxygen-induced retinopathy (OIR), exogenous factors such as oxygen levels, “oxidative stress,” inflammation, and nutritional capacity have been linked to severe ROP through dysregulated signaling pathways involving hypoxia inducible factors and angiogenic factors like VEGF, oxidative species, and neuroprotective growth factors to cause “phases” of ROP. This translational science review will focus on studies performed in animal models of OIR representative of human ROP and highlight several areas: mechanisms for aberrant growth of blood vessels into the vitreous rather than into the retina through over activation of VEGF receptor 2 (VEGFR2) signaling, the importance of targeting different cells into the retina in order to inhibit aberrant angiogenesis and promote physiologic retinal vascular development, toxicity from broad and targeted inhibition of VEGF bioactivity, and the role of VEGF in neuroprotection in retinal development. Several future translational treatments are discussed, including considerations for targeted inhibition of VEGF signaling instead of broad intravitreal anti-VEGF treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International Classification of Retinopathy of Prematurity Revisited
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.7.991 · Cited by 2,932
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., et al. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302047 · Cited by 2,894
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1684 · Cited by 1,679
Oxygen-induced retinopathy in the mouse.
Smith, L. E. H., Wesolowski, E., McLellan, A., Kostyk, S. K., D’Amato, R. J., Sullivan, R., & D'Amore, P. A. (1994) · PubMed · Cited by 1,627
Screening Examination of Premature Infants for Retinopathy of Prematurity
Fierson, W. M., AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology, AMERICAN ACADEMY OF OPHTHALMOLOGY, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS, Chiang, M. F., Good, W., Phelps, D., Reynolds, J., Robbins, S. L., et al. (2018) · Pediatrics · doi:10.1542/peds.2018-3061 · Cited by 1,460
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Mintz-Hittner, H. A., Kennedy, K. A., & Chuang, A. Z. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007374 · Cited by 1,455
Gole, G. A., Ells, A. L., Katz, X., Holmström, G. E., Fielder, A. R., Capone, A., Flynn, J. T., Good, W., Holmes, J. M., McNamara, J. A., et al. (2005) · Archives of Ophthalmology · Cited by 1,386
Hellström, A., Smith, L. E., & Dammann, O. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60178-6 · Cited by 1,304
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1769 · Cited by 1,001
Gilbert, C. (2008) · Early Human Development · doi:10.1016/j.earlhumdev.2007.11.009 · Cited by 790
Mechanisms and Management of Retinopathy of Prematurity
Hartnett, M. E., & Penn, J. S. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1208129 · Cited by 637
Self-citationScreening Examination of Premature Infants for Retinopathy of Prematurity
AMERICAN ACADEMY OF PEDIATRICS Section on Ophthalmology, AMERICAN ACADEMY OF OPHTHALMOLOGY, AMERICAN ASSOCIATION FOR PEDIATRIC OPHTHALMOLOGY AND STRABISMUS, AMERICAN ASSOCIATION OF CERTIFIED ORTHOPTISTS, Fierson, W. M., Saunders, R. A., Good, W., Palmer, E. A., Phelps, D., Reynolds, J., et al. (2013) · Pediatrics · doi:10.1542/peds.2012-2996 · Cited by 588
Higashiyama, T., Muraki, S., & Ohji, M. (2017) · Case Reports in Ophthalmology · doi:10.1159/000461575 · Cited by 448
Prognostic Factors in the Natural Course of Retinopathy of Prematurity
Schaffer, D. B., Palmer, E. A., Plotsky, D. F., Metz, H. S., Flynn, J. T., Tung, B., & Hardy, R. J. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31665-9 · Cited by 403
Chan‐Ling, T., Gock, B., & Stone, J. (1995) · PubMed · Cited by 282
Penn, J. S., Henry, M. M., & Tolman, B. L. (1994) · Pediatric Research · doi:10.1203/00006450-199412000-00007 · Cited by 269
Müller cell‐derived VEGF is a significant contributor to retinal neovascularization
Bai, Y., Ma, J., Guo, J., Wang, J., Zhu, M., Chen, Y., & Le, Y. (2009) · The Journal of Pathology · doi:10.1002/path.2611 · Cited by 238
Transcutaneous oxygen levels in retinopathy of prematurity
Cunningham, S., Mclntosh, N., Fleck, B. W., & Elton, R. A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92475-2 · Cited by 195
Chen, J., Connor, K. M., Aderman, C. M., Willett, K. L., Aspegren, O. P., & Smith, L. E. H. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2521 · Cited by 178
Zeng, G., Taylor, S. M., McColm, J. R., Kappas, N. C., Kearney, J. B., Williams, L. H., Hartnett, M. E., & Bautch, V. L. (2006) · Blood · doi:10.1182/blood-2006-07-037952 · Cited by 147
Self-citationAstrocyte–Endothelial Cell Relationships during Human Retinal Vascular Development
Chan‐Ling, T., McLeod, D. S., Hughes, S., Baxter, L., Chu, Y., Hasegawa, T., & Lutty, G. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1169 · Cited by 145
Genetic Susceptibility to Retinopathy of Prematurity
Bizzarro, M. J., Hussain, N., Jónsson, B., Feng, R., Ment, L. R., Gruen, J. R., Zhang, H., & Bhandari, V. (2006) · PEDIATRICS · doi:10.1542/peds.2006-1088 · Cited by 135
McColm, J. R., Geisen, P., & Hartnett, M. E. (2004) · PubMed · Cited by 126
Self-citationProlyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy
Sears, J. E., Hoppe, G., Ebrahem, Q., & Anand‐Apte, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805817105 · Cited by 116
Understanding Retinopathy of Prematurity: Update on Pathogenesis
Rivera, J. C., Sapieha, P. S., Joyal, J., Duhamel, F., Shao, Z., Sitaras, N., Picard, É., Zhou, T. E., Lachapelle, P., & Chemtob, S. (2011) · Neonatology · doi:10.1159/000330174 · Cited by 114
Niesman, M. R., Johnson, K. A., & Penn, J. S. (1997) · Neurochemical Research · doi:10.1023/a:1022474120512 · Cited by 110
Hartnett, M. E., Martiniuk, D., Byfield, G. E., Geisen, P., Zeng, G., & Bautch, V. L. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1780 · Cited by 110
Self-citationTokunaga, C. C., Mitton, K. P., Dailey, W., Massoll, C., Roumayah, K. K., Guzman, E., Tarabishy, N., Cheng, M., & Drenser, K. A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13397 · Cited by 101
Saito, Y., Uppal, A., Geisen, P., & Hartnett, M. E. (2020) · PubMed Central · doi:10.17615/fn4f-9z34 · Cited by 99
Self-citationThe initial fetal human retinal vasculature develops by vasculogenesis
McLeod, D. S., Hasegawa, T., Prow, T. W., Merges, C. A., & Lutty, G. A. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20988 · Cited by 87
Greenberg, K. P., Geller, S. F., Schaffer, D. V., & Flannery, J. G. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1570 · Cited by 79
Effect of VEGF Trap on Normal Retinal Vascular Development and Oxygen-Induced Retinopathy in the Dog
Lutty, G. A., McLeod, D. S., Bhutto, I. A., & Wiegand, S. J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6798 · Cited by 79
Wang, H., Yang, Z., Jiang, Y., & Hartnett, M. E. (2014) · PubMed Central · Cited by 77
Self-citationHolmes, J. M., & Duffner, L. A. (1996) · Current Eye Research · doi:10.3109/02713689608995831 · Cited by 72
VEGFA Activates Erythropoietin Receptor and Enhances VEGFR2-Mediated Pathological Angiogenesis
Yang, Z., Wang, H., Jiang, Y., & Hartnett, M. E. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.12.023 · Cited by 67
Self-citationWang, H., Zhang, S. X., & Hartnett, M. E. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.986 · Cited by 64
Self-citationHartnett, M. E., Morrison, M. A., Smith, S. E., Yanovitch, T. L., Young, T. L., Colaizy, T. T., Momany, A. M., Dagle, J. M., Carlo, W. A., Clark, E., et al. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14841 · Cited by 62
Self-citationByfield, G. E., Budd, S., & Hartnett, M. E. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3256 · Cited by 61
Self-citationWang, H., Byfield, G. E., Jiang, Y., Smith, G. W., McCloskey, M., & Hartnett, M. E. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.031 · Cited by 57
Self-citationHartnett, M. E. (2010) · PubMed · Cited by 56
Self-citationWang, H., Smith, G. W., Yang, Z., Jiang, Y., McCloskey, M., Greenberg, K. P., Geisen, P., Culp, W. D., Flannery, J. G., Kafri, T., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.011 · Cited by 54
Self-citationJiang, Y., Wang, H., Culp, D., Yang, Z., Fotheringham, L., Flannery, J. G., Hammond, S. M., Kafri, T., & Hartnett, M. E. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13755 · Cited by 52
Self-citationThe Role of Cytochrome P450 Epoxygenases in Retinal Angiogenesis
Capozzi, M. E., McCollum, G. W., & Penn, J. S. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14216 · Cited by 40
Penn, J. S., & Rajaratnam, V. S. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0804 · Cited by 35
Wang, H., Yang, Z., Jiang, Y., Flannery, J. G., Hammond, S. M., Kafri, T., Vemuri, S. K., Jones, B. W., & Hartnett, M. E. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13429 · Cited by 28
Self-citation
Cited by
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Suzumura, A., Terao, R., & Kaneko, H. (2020) · Antioxidants · doi:10.3390/antiox9100920 · Cited by 44
CCN1–Yes-Associated Protein Feedback Loop Regulates Physiological and Pathological Angiogenesis
Lee, S., Ahad, A., Luu, M., Moon, S., Caesar, J., Cardoso, W. V., Grant, M. B., & Chaqour, B. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00107-19 · Cited by 26
Metadata
- Authors
- Hartnett, M. E.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 122
- Issue
- 1
- Pages
- 200-210
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2139769620
- Cited by
- 351
- References
- 45
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.